Omalizumab Therapeutic Cheat Sheet
Chronic idiopathic urticaria is urticaria for greater than 6 weeks without an identifiable trigger. Cases relapse in 20% of patients for more than 5 years and be difficult to manage; however, omalizumab is a recently approved option for treatment of chronic idiopathic urticaria showing beneficial outcomes.1 Omalizumab is an injectable monoclonal antibody that has been FDA approved not just for chr …
Chronic idiopathic urticaria is urticaria for greater than 6 weeks without an identifiable trigger. Cases relapse in 20% of patients for more than 5 years and be difficult to manage; however, omalizumab is a recently approved option for treatment of chronic idiopathic urticaria showing beneficial outcomes.1 Omalizumab is an injectable monoclonal antibody that has been FDA approved not just for chr … 
Atopic dermatitis is a common, chronic, life-altering disease. With its visibility and debilitating pruritus, atopic dermatitis significantly impacts our patients’ quality of life. For those with resistant and extensive disease, we are happy to have numerous new systemic agents at our disposal, one being tralokinumab, an IL-13 antagonist. We continue our series, Therapeutic Cheat Sheet, with a c … 
Disorders of the hair follicles, including hidradenitis suppurativa and folliculitis, are some of the most common dermatologic conditions affecting a wide variety of patients. Chlorhexidine’s bacteriostatic and bacteriocidal properties enable it to be a potent defender of the pilosebaceous unit. We continue our series, Therapeutic Cheat Sheet, with a closer look at chlorhexidine, which has far r … 
Thalidomide was introduced in the 1950s as a “safe” sleeping medication; however, it quickly became vilified and was removed from the market for its severe teratogenic effects, most commonly phecomelia, or loss of arms and legs. Despite these devastating birth defects, thalidomide has a variety of indications for dermatologic conditions, with manageable side effects when used appropriately. We … 
Pruritus, whether related to inflammatory skin conditions or systemic disease, can be debilitating for patients. In order to improve quality of life for patients suffering from severe pruritus, dermatologists often resort to off-label use of systemic medications. In this month’s installment of our Therapeutic Cheat Sheet Series, we will discuss use of naltrexone for treatment of pruritus.
Naltr … 